Fulgent Genetics, Inc.FLGTNASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank45
3Y CAGR-33.9%
5Y CAGR-27.7%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
-33.9%/yr
vs +88.1%/yr prior
5Y CAGR
-27.7%/yr
Recent deceleration
Acceleration
-122.1pp
Decelerating
Percentile
P45
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 28.70% |
| 2024 | -4.69% |
| 2023 | -13.02% |
| 2022 | 99.53% |
| 2021 | 149.18% |
| 2020 | 145.02% |
| 2019 | 20.85% |
| 2018 | 7.95% |
| 2017 | 33.34% |
| 2016 | 39.11% |